Bacterial antibiotic efflux systems of medical importance

Cellular and Molecular Life Sciences

Volumn 56, Issue 9-10, 1999, Pages 771-778

  Köhler, Thilo ^a   Pechere J C ^a   Plesiat P ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Efflux; Microorganisms; Multidrug resistance; Resistance mechanism

Indexed keywords

ANTIBIOTIC AGENT; CARRIER PROTEIN; LINCOSAMIDE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL OUTER MEMBRANE; CONFERENCE PAPER; DRUG ACCUMULATION; DRUG TRANSPORT; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MEMBRANE PERMEABILITY; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STREPTOCOCCUS;

PSEUDOMONAS AERUGINOSA;

EID: 0032695922     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050024     Document Type: Conference Paper

References (62)

1. Levy S. B. and McMurry L. (1978) Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature 276: 90-92
2. McMurry L. and Levy S. B. (1978) Two transport systems for tetracycline in sensitive Escherichia coli: Critical role for an initial rapid uptake system insensitive to energy inhibitors. Antimicrob. Agents Chemother. 14: 201-209
3. Levy S. B. (1992) Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36: 695-703
4. Nikaido H. (1996) Multidrug efflux pumps of Gram-negative bacteria. J. Bacteriol. 178: 5853-5859
5. Jenkinson H. F. (1996) Ins and outs of antimicrobial resistance: Era of the drug pumps. J. Dent. Res. 75: 736-742
6. Saier M. H. J., Paulsen I. T., Sliwinski M. K., Pao S. S., Skurray R. A. and Nikaido H. (1998) Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J. 12: 265-274
7. Marger M. D. and Saier M. H. J. (1993) A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends. Biochem. Sci. 18: 13-20
8. Paulsen I. T., Skurray R. A., Tam R., Saier M. H. J., Turner R. J., Weiner J. H. et al. (1996) The SMR family: A novel family of multidrug efflux proteins involved with the efflux of lipophitic drugs. Mol. Microbiol. 19: 1167-1175
9. Paulsen I. T., Brown M. H. and Skurray R. A. (1998) Characterization of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system J. Bacteriol. 180: 3477-3479
10. Paulsen I. T., Brown M. H., Dunstan S. J. and Skurray R. A. (1995) Molecular characterization of the staphylococcal multidrug resistance export protein QaeC. J. Bacteriol. 177: 2827-2833
11. Ross J. I., Eady E. A., Cove J. H., Cunliffe W. J., Baumberg S. and Wootton J. C. (1990) Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4: 1207-1214
12. Paulsen I. T., Brown M. H. and Skurray R. A. (1996) Proton-dependent multidrug efflux systems. Microbiol. Rev. 60: 575-608
13. Yoshida H., Bogaki M., Nakamura S., Ubukata K. and Konno M. (1990) Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172: 6942-6949
14. Kaatz G. W. and Seo S. M. (1997) Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 41: 2733-2737
15. Hsieh P. C., Siegel S. A., Rogers B., Davis D. and Lewis K. (1998) Bacteria lacking a multidrug pump: A sensitive tool for drug discovery. Proc. Natl. Acad. Sci. USA 95: 6602-6606
16. Schmitz F. J., Hertel B., Hofmann B., Scheuring S., Verhoef J., Fluit A. C. et al. (1998) Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. J. Antimicrob. Chemother. 42: 561-563
17. Guay G. G., Khan S. A. and Rothstein D. M. (1993) The tet(K) gene of plasmid pT181 of Staphylococcus aureus encodes an efflux protein that contains 14 transmembrane helices. Plasmid 30: 163-166
18. Warsa U. C., Nonoyama M., Ida T., Okamoto R., Okubo T., Shimauchi C. et al. (1996) Detection of tet(K) and tet(M) in Staphylococcus aureus of Asian countries by the polymerase chain reaction. J. Antibiot. (Tokyo) 49: 1127-1132
19. Matsuoka M., Endou K., Saitoh S., Katoh M. and Nakajima Y. (1995) A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary. Biol. Pharm Bull. 18: 1482-1486
20. Eady E. A., Ross J. I., Tipper J. L., Walters C. E., Cove J. H. and Noble W. C. (1993) Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 31: 211-217
21. Matsuoka M., Endou K., Kobayashi H., Inoue M. and Nakajima Y. (1998) A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol. Lett. 167: 221-227
22. Matsuoka M., Endou K., Kobayashi H., Inoue M. and Nakajima Y. (1997) A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 148: 91-96
23. Brenwald N. P., Gill M. J. and Wise R. (1998) Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42: 2032-2035
24. Gill M. J., Brenwald N. P. and Wise R. (1999) Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43: 187-189
25. Shortridge V. D., Flamm R. K., Ramer N., Beyer J. and Tanaka S. K. (1996) Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 26: 73-78
26. Sutcliffe J., Tait-Kamradt A. and Wondrack L. (1996) Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides bur sensitive to clindamycin: A common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40: 1817-1824
27. Clancy J., Petitpas J., Dib-Hajj F., Yuan W., Cronan M., Kamath A. V. et al. (1996) Molecular cloning and functional analysis of a novel macrolide- resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22: 867-879
28. Tait-Kamradt A., Clancy J., Cronan M., Dib-Hajj F., Wondrack L., Yuan W. et al. (1997) mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41: 2251-2255
29. Kataja J., Seppala H., Skurnik M., Sarkkinen H. and Huovinen P. (1998) Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob. Agents Chemother. 42: 1493-1494
30. Johnston N. J., De Azavedo J. C., Kellner J. D. and Low D. E. (1998) Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42: 2425-2426
31. Widdowson C. A. and Klugman K. P. (1998) Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg. Infect. Dis. 4: 277-281
32. Fraimov and Knob. (1997) ASM abstract
33. Lynch C., Courvalin P. and Nikaido H. (1997) Active efflux of antimicrobial agents in wild-type strains of enterococci. Antimicrob. Agents Chemother. 41: 869-871
34. Nikaido H. and Vaara M. (1985) Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49: 1-32
35. Rella M. and Haas D. (1982) Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: Mapping of chromosomal genes. Antimicrob. Agents Chemother. 22: 242-249
36. Aubert G., Pozzetto B. and Dorche G. (1992) Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. J. Antimicrob. Chemother. 29: 307-312
37. Robillard R. A. and Scarpa A. L. (1988) Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO. Antimicrob. Agents Chemother. 32: 535-539
38. Poole K., Krebes K., McNally C. and Neshat S. (1993) Multiple antibiotic resistance in Pseudomonas aeruginosa: Evidence for involvement of an efflux operon. J. Bacteriol. 175: 7363-7372
39. Poole K., Gotoh N., Tsujimoto H., Zhao Q., Wada A., Yamasaki T. et al. (1996) Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21: 713-724
40. Köhler T., Michea-Hamzehpour M., Henze U., Gotoh N., Curty L. K. and Pechère J. C. (1997) Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23: 345-354
41. Ramos-Aires J., Köhler T., Nikaido H. and Plésiat P. (1999) Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43: 2624-2628
42. Mine T., Morita Y., Kataoka A., Mizushima T. and Tsuchiya T. (1999) Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: 415-417
43. Li X.-Z., Ma D., Livermore D. M. and Nikaido H. (1994) Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Active efflux as contributing factor to β-lactam resistance. Antimicrob. Agents Chemother. 38: 1742-1752
44. Li X.-Z., Livermore D. M. and Nikaido H. (1994) Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Resistance to tetracycline, chloramphenicol and norfloxacin. Antimicrob. Agents Chemother. 38: 1732-1741
45. Köhler T., Kok M., Michea-Hamzehpour M., Plesiat P., Gotoh N., Nishino T. et al. (1996) Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40: 2288-2290
46. Li X. Z., Zhang L. and Poole K. (1998) Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J. Bacteriol. 180: 2987-2991
47. Masuda N. and Ohya S. (1992) Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36: 1847-1851
48. Köhler T., Michea-Hamzehpour M., Epp S. F. and Pechere J. C. (1999) Carbapenem activities in Pseudomonas aeruginosa: Respective contribution of OprD and efflux systems. Antimicrob. Agents Chemother. 43: 424-427
49. Li X.-Z., Nikaido H. and Poole K. (1995) Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39: 1948-1953
50. Poole K., Tetro K., Zhao Q., Neshat S., Heinrichs D. E. and Bianco N. (1996) Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40: 2021-2028
51. Okazaki T. and Hirai K. (1992) Cloning and nucleotide sequence of the Pseudomonas aeruginosa nfxB gene, conferring resistance to new quinolones. FEMS Microbiol. Lett. 97: 197-202
52. Köhler T., Epp S. F., Kocjancic-Curty L. and Pechere J. C. (1999) Characterization of MexT, the transcriptional activator of the MexEF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 181: 6300-6305
53. Köhler T., Michéa-Hamzehpour M, Plésiat P., Kahr A. and Pechère J. C. (1997) Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41: 2540-2543
54. Michéa-Hamzehpour M., Auckenthaler R., Régamay P. and Pechère J.-C. (1987) Rcsistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob. Agents Chemother. 31: 1803-1808
55. Fukuda H., Hosaka M., Iyobe S., Gotoh N., Nishino T. and Hirai K. (1995) nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39: 790-792
56. Jakics E. B., Iyobe S., Hirai K., Fukuda H. and Hashimoto H. (1992) Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36: 2562-2565
57. Yoshida H., Nakamura M., Bogaki M. and Nakamura S. (1990) Proportion of DNA gyrase mutants among quinolone resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34: 1273-1275
58. Cambau E., Perani E., Dib C., Petinon C., Trias J. and Jarlier V. (1995) Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant tu imipenem. Antimicrob. Agents Chemother. 39: 2248-2252
59. Ziha-Zarifi I., Llanes C., Köhler T., Pechere J. C. and Plesiat P. (1998) In vivo emergence of multidrug resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother. 43: 287-291
60. Hagman K. E., Pan W., Spratt B. G., Balthazar J. T., Judd R. C. and Shafer W. M. (1995) Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141: 611-622
61. Veal W. L., Yellen A., Balthazar J. T., Pan W., Spratt B. G. and Shafer W. M. (1998) Loss-of-function mutations in the mtr efflux system of Neisseria gonorrhoeae. Microbiology 144: 621-627
62. Shafer W. M., Balthazar J. T., Hagman K. E. and Morse S. A. (1995) Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology 141: 907-911